Northwestern filed a lawsuit against Moderna Wednesday alleging the company misused the University’s patented lipid ...

Based in Cambridge, Massachusetts, Moderna, Inc. (MRNA) is a leading biotechnology company that develops messenger RNA (mRNA) ...

Zylem Biosciences announced that Northwestern University has filed a lawsuit against Moderna (MRNA), alleging infringement of key patents ...

TD Cowen analyst Tyler Van Buren has maintained their neutral stance on MRNA stock, giving a Hold rating on October 17. Tyler Van ...

The latest trading session saw Moderna (MRNA) ending at $53.80, denoting a -0.55% adjustment from its last day's close. The stock's performance was behind the S&P 500's daily loss of 0.18%. Elsewhere, ...

Moderna (MRNA) reachead $53.80 at the closing of the latest trading day, reflecting a -0.55% change compared to its last close. We recently compiled a list of the 10 Best QQQ Stocks to Buy ...

High-dose flu vaccinations resulted in a 23% reduction in hospitalizations among people aged 65 years or older, according to ...

The large inflow of cash from Comirnaty gross profits in 2021-22 has further secured BioNTech's financial health. Outside of BioNTech’s covid-19 vaccine candidates, we think the earliest approval ...

Rolling carts are a favorite of professional organizers and design experts who love the slim footprint, deep storage ...

Stocks today are moderately lower as a jump in global bond yields undercuts equity prices.  The 10-year T-note yield rose to a 2-3/4 month high today, the 10-year German bund yield climbed to a 7-week ...